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Background: Idiopathic thoracic aortic mural thrombi are rare. They can be responsible for dramatic systemic
embolization. Early treatment is imperative because of their high morbidity and mortality rate.
Case presentation: A 55-year-old previously healthy Moroccan male came in an array of acute right lower limbs pain
and abdominal sensibility. Severe systemic embolism involving the lower extremities, spleen, kidney, and digestive tract,
due to an idiopathic mural thrombus of the thoracic aorta was diagnosed. He received medical treatment leading to
the complete disappearance of the thrombus and the effects caused by the latter.
Conclusions: When faced unexplained peripheral embolization, research for a thrombus of the thoracic aorta should
be performed. Medical treatment should be considered for its management, especially in patients with high surgical
risk.
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Thoracic Aortic mural thrombus (TAMT) accounts for
0.9% of all aetiologies of peripheral arterial embolism
and is responsible for significant morbidity and mortality
[1]. Its most frequent origins are intra cardiac or intra
aneurismal thrombus, atherosclerotic aortic lesions, ven-
ous paradoxical embolization, malignant diseases, trauma,
coagulation disorders, and certain systemic and rheumatic
diseases.
Idiopathic or isolated thoracic aortic mural thrombus
(IAMT) developing in the absence of aortic lesion, cardiac,
hematologic or haemostatic disorders, are much more
rare [2]. Currently, the common use of computed tomog-
raphy (CT), transesophageal echocardiography (TEE) and
magnetic resonance imaging (MRI) has facilitated the
early diagnosis of this condition, which is still without a
set treatment [1,3]. We recount the medical management
of a patient with an IAMT revealed by severe peripheral
and visceral embolism. We will then recall the diagnostic* Correspondence: drabissyves@gmail.com
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unless otherwise stated.and therapeutic methods recommended in the treatment
of this rare condition.
Case presentation
A 55-year-old Moroccan male came into the emergency
department with abdominal pain, vomiting, and lower
right limb pain. He had consulted two days earlier at a
different health centre and was prescribed an anti-
inflammatory and anti spasmodic. He reported no im-
provements. He was a former smoker, weaned for
10 years, and had a history of hypothyroidism treated
with Levothyroxine.
Physical examination on admission found coldness and
paresis of the right ankle and foot, associated with the ab-
sence of popliteal, posterior and pedal tibia pulses. The left
leg showed no anomaly. His abdomen was sensitive but
without signs of peritonitis. Blood pressure was 138/
85 mmHg with sinus tachycardia at 134 beats/min.
Arterial and venous Duplex ultrasonography of the
lower limb, showed thrombosis of the popliteal arteries
and tibial tripod. There were no signs of deep venous
thrombosis. Transthoracic echocardiography (TTE) showed
neither valvular nor intra cavitary anomalies. Ventricular
ejection fraction was preserved. Laboratory tests notedtral. This is an Open Access article distributed under the terms of the Creative
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11902 IU/L, LDH at 623 IU/L, (troponin I was normal),
white blood cells (WBC) count at 13×109/L and high C-
reactive protein (CRP) level at 500 mg/L. Renal function
was impaired; urea 13.6 mmol/l, creatinine 221 μmol/l,
measured creatinine clearance at 27 ml/min. His diuresis
was conserved. Coagulation and crasis tests were normal.
Blood samples were taken for assessment of thrombophi-
lia (protein S, protein C, Antithrombin III).
Embolectomy of the sub articular popliteal artery was
performed under local anaesthesia. Fresh thrombus was
extracted from the popliteal artery with recovery of good
flows. But embolectomy of the leg arteries revealed an
old and adhering thrombus with poor reflux. Fasciotomy
of the leg completed the surgery. He was subsequently
admitted in intensive care (ICU) and received sodium
heparin (500 IU/Kg/24 h) using an automatic syringe,
antibiotics, an analgesic and a proton pump inhibitor
(PPIs). Oral feeding was stopped.
The next morning, coldness of the left lower limb was
found with the abolition of the distals pulses. We real-
ized a thoraco-abdominal and lower limb angio CT. It
showed the thoracic aorta of normal size with no par-
ietal atherosclerotic lesion and containing a thrombus
measuring 43 mm whose upper pole was located at
15 mm of the aortic isthmus (Figure 1A, B, E), and signs
of renal and splenic infarction, very thin colonic wall notFigure 1 CT angiography showing the thoracic aorta of normal caliber wit
section; A, B. Sagittal reconstruction; E. Kidney infarct and peri-splenic hemenhanced by the contrast agen, suggestive of ischemia
(Figure 1B, C). The arteries of the lower limbs were oc-
cluded beginning at the popliteal artery (Figure 2).
Surgical treatment of the aortic thrombus was pro-
posed, but patient and his family who were made aware
of the surgical risks refused. The dose of heparin was in-
creased (700 IU/Kg/24 h), associated with Naftidrofuryl
(Praxilene® 200 mg) 2 tablets/8 h. On D4, amputation of
the right thigh was carried out because of the extension
of the lesions on this limb, a constant hyperleukocytosis
and a high CRP level. However the coldness of the lower
left limb had disappeared.
From D10 we finally began the introduction of oral
anticoagulation (OAC) by vitamin K antagonists, Aceno-
coumarol (sintrom® 4 mg). INR target (2–3) was obtained
after 3 days of overlap. We didn’t introduce them earlier
because the surgical option was not abandoned and the
decision for medical treatment had not yet been taken.
Renal function was stabilized, as well as WBC count and
CRP levels. TEE could not be realized due to technical
reasons, so we did another CT scan (Figure 3), which
showed the persistence of intra aortic thrombus, pleural
effusions, and the appearance of thrombus tracks in the
right and left pulmonary artery branches.
At D21, his condition improved and he was transferred to
the inpatient ward. One week later, at his request, he was
discharged but kept under treatment, which comprised ofhout parietal atherosclerotic lesion, with an intra-aortic thrombus. Axial
atoma, axial section C, D.
Figure 2 CT angiography of the lower limbs showing. Right; poor
patency of the operated arterial axis, and Left; a change in contrast
at the beginning of the popliteal artery.
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covered during his hospitalization.
A new thrombophilia assessment was carried on con-
sultation at the department of Internal Medicine. No ab-
normalities were found.
CT scan realized 2 months later showed a complete
recanalization of the thoracic aorta with disappearance
of the thrombus (Figure 4). 10 months after this episode,
the patient presented no embolic recurrence. His thigh
was fitted and he is still under OAC.
Discussion
The usual mode of revelation of IAMT is critical limb is-
chemia often associated with abdominal pain in patients
without obvious risk factors for thromboembolic dis-
eases [1,2]. Embolic source must be quickly identified
and localized to avoid a potential recurrence or fatal
evolution.
TEE is considered the examination of choice for the
diagnosis and evaluation of IAMT. Its diagnostic efficiency
would be 50% in patients with peripheral arterial embol-
ism in the absence of significant cardiac disease [3]. It
would also provide information on the size of the mass, its
morphological layout (pediculate or sessile), and its dy-
namic or static characteristics, location, and appearance of
the aortic wall. This has a great importance for the thera-
peutic choice. Its main limitations are incomplete
visualization of the aorta and the need for it to be done
under general anaesthesia in unstable patients [4].
Angio CT and MRI are also very effective for the diag-
nosis of aortic masses. These tests allow a study of the
entire aorta and to eliminate an aortic aneurysm or ath-
erosclerotic or calcified lesions. MRI may be more sensi-
tive in detecting a thrombus.
Presently, it is recommended to use angio CT or MRI
combined with TEE for the detection and evaluation of
thrombus of the thoracic aorta [1,4]. In addition to the
morphological examinations, haematological evaluation
and cardiovascular assessment should be performed [5].
In our case, the etiological investigation found no hema-
tological abnormalities. His only cardiovascular risk fac-
tors were his former smoking, and hypercholesterolemia
uncovered during hospitalization.
There is still no consensus on the treatment of IAMT.
According to Fayad et al. [6], aortic surgery should be
considered as first-line treatment, especially for patients
with a high risk of relapse. Treating with anticoagulation
only would be associated with a higher recurrence risk
and incidence of complications such as loss of a limb.
The techniques used are varied and often complex
ranging from thrombectomy/embolectomy by sternot-
omy or left thoracotomy, often with the establishment of
an atrio-femoral shunt or cardiopulmonary bypass [7].
Endovascular procedures that allow the exclusion of
Figure 3 CT angiography showing a thrombus in the pulmonary artery branches. Axial section A; bilateral pleural effusions, Axial A and B;
persistence of intra aortic thrombus. Axial section A and B and sagittal reconstruction C.
Figure 4 CT angiography showing a complete reversal of the thoracic aorta with disappearance of thrombus. Axial section A and sagittal
reconstruction C. Notch sequelae of kidney infarct, axial section B.
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They require, however, a careful selection of patients in
relation to the location of thrombus and the anatomical
conditions of the aorta. Their main complication is the
increased risk of thrombus migration when navigating in
the aorta or during stent-graft deployment. These op-
tions represent sensitive procedures, difficult to imple-
ment in units not trained in this type of interventions.
The choosing of medical treatment as a first resort is
making a comeback. Whether anticoagulation or sys-
temic thrombolysis [5,10,11], these options would help
to reduce morbidity and the length of stay at the hos-
pital in patients for whom they are suitable [5].
In the study of Turley [5], 83% patients treated with
anticoagulation only and the single patient treated by
thrombolysis, experienced a complete resolution of the
thrombus with a single case of complication being a
major amputation.
Others suggest treatment with heparin when finding a
mobile thrombus in the aorta, and reassessment by TEE
after 15 days of treatment [12]. Surgical treatment will
be offered only after failure of medical treatment to pa-
tients in whom other causes of embolic events have been
excluded. Selection criteria include young age, recurrent
embolic events, and the high mobility of the thrombus.
After thrombectomy, long-term treatment by anticoagu-
lants and regular monitoring by TEE or angio CT, an
MRI is necessary due to the high risk of relapse.
In our case, due to the highly volatile state of the pa-
tient, as well as surgical risks, the medical option seemed
to have been the best choice in light of the results
obtained.Conclusions
IAMT are rare conditions that can be associated with
embolic events in a patient with no predisposing factors.
Despite the development of surgical and endovascular
procedures, medical care should be considered in high
surgical risk patients.Consent
Written informed consent was obtained from the patient
for publication of this case report. Copies of the written
consent are available for review by the Editor-in-Chief of
this journal.
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